Literature DB >> 17657831

Colorectal carcinogenesis: road maps to cancer.

Daniel-L Worthley1, Vicki-L Whitehall, Kevin-J Spring, Barbara-A Leggett.   

Abstract

This review explores the chief genetic and epigenetic events that promote pathological progression in colorectal carcinogenesis. This article discusses the molecular and pathological basis for classifying colorectal neoplasia into suppressor, mutator and methylator pathways. These differing mechanisms of genomic instability are associated with specific cancer characteristics, and may provide the opportunity for more effective prevention and surveillance strategies in the future. This is the first review in a series of five topics outlining important and developing aspects of colorectal cancer.

Entities:  

Mesh:

Year:  2007        PMID: 17657831      PMCID: PMC4611209          DOI: 10.3748/wjg.v13.i28.3784

Source DB:  PubMed          Journal:  World J Gastroenterol        ISSN: 1007-9327            Impact factor:   5.742


  66 in total

1.  Colonoscopic screening of persons with suspected risk factors for colon cancer: II. Past history of colorectal neoplasms.

Authors:  S Grossman; M L Milos; I S Tekawa; N P Jewell
Journal:  Gastroenterology       Date:  1989-02       Impact factor: 22.682

Review 2.  Evolution of colorectal cancer: change of pace and change of direction.

Authors:  Jereny R Jass; Joanne Young; Barbara A Leggett
Journal:  J Gastroenterol Hepatol       Date:  2002-01       Impact factor: 4.029

3.  Characterisation of colorectal cancers showing hypermethylation at multiple CpG islands.

Authors:  M van Rijnsoever; F Grieu; H Elsaleh; D Joseph; B Iacopetta
Journal:  Gut       Date:  2002-12       Impact factor: 23.059

Review 4.  CpG island methylator phenotype in cancer.

Authors:  Jean-Pierre Issa
Journal:  Nat Rev Cancer       Date:  2004-12       Impact factor: 60.716

5.  Natural history of untreated colonic polyps.

Authors:  S J Stryker; B G Wolff; C E Culp; S D Libbe; D M Ilstrup; R L MacCarty
Journal:  Gastroenterology       Date:  1987-11       Impact factor: 22.682

6.  Mutations in APC, Kirsten-ras, and p53--alternative genetic pathways to colorectal cancer.

Authors:  Gillian Smith; Francis A Carey; Julie Beattie; Murray J V Wilkie; Tracy J Lightfoot; Jonathan Coxhead; R Colin Garner; Robert J C Steele; C Roland Wolf
Journal:  Proc Natl Acad Sci U S A       Date:  2002-07-01       Impact factor: 11.205

7.  p21(Waf1/Cip1) inhibition of cyclin E/Cdk2 activity prevents endoreduplication after mitotic spindle disruption.

Authors:  Z A Stewart; S D Leach; J A Pietenpol
Journal:  Mol Cell Biol       Date:  1999-01       Impact factor: 4.272

Review 8.  The colorectal adenoma-carcinoma sequence.

Authors:  A Leslie; F A Carey; N R Pratt; R J C Steele
Journal:  Br J Surg       Date:  2002-07       Impact factor: 6.939

Review 9.  Microsatellite instability in colorectal cancer.

Authors:  K Söreide; E A M Janssen; H Söiland; H Körner; J P A Baak
Journal:  Br J Surg       Date:  2006-04       Impact factor: 6.939

Review 10.  Aneuploidy and cancer.

Authors:  Harith Rajagopalan; Christoph Lengauer
Journal:  Nature       Date:  2004-11-18       Impact factor: 49.962

View more
  49 in total

1.  Overexpression of Evi-1 oncoprotein represses TGF-β signaling in colorectal cancer.

Authors:  Xiyun Deng; Yanna Cao; Yan Liu; Fazhi Li; Kamalanathan Sambandam; Srinivasan Rajaraman; Archibald S Perkins; Alan P Fields; Mark R Hellmich; Courtney M Townsend; E Aubrey Thompson; Tien C Ko
Journal:  Mol Carcinog       Date:  2011-12-07       Impact factor: 4.784

2.  Effects of calcium and vitamin D on MLH1 and MSH2 expression in rectal mucosa of sporadic colorectal adenoma patients.

Authors:  Eduard Sidelnikov; Roberd M Bostick; W Dana Flanders; Qi Long; Veronika Fedirko; Aasma Shaukat; Carrie R Daniel; Robin E Rutherford
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2010-03-23       Impact factor: 4.254

3.  Implication of K-ras and p53 in colorectal cancer carcinogenesis in Tunisian population cohort.

Authors:  Chaar Ines; Ounissi Donia; Boughriba Rahma; Azza Ben Ammar; Amara Sameh; Taher Khalfallah; Ben Hmida Abdelmajid; Mzabi Sabeh; Bouraoui Saadia
Journal:  Tumour Biol       Date:  2014-04-25

Review 4.  Colorectal carcinogenesis--update and perspectives.

Authors:  Hans Raskov; Hans-Christian Pommergaard; Jakob Burcharth; Jacob Rosenberg
Journal:  World J Gastroenterol       Date:  2014-12-28       Impact factor: 5.742

5.  Deficient DNA mismatch repair is associated with favorable prognosis in Thai patients with sporadic colorectal cancer.

Authors:  Krittiya Korphaisarn; Ananya Pongpaibul; Chanin Limwongse; Ekkapong Roothumnong; Wipawi Klaisuban; Akarin Nimmannit; Artit Jinawath; Charuwan Akewanlop
Journal:  World J Gastroenterol       Date:  2015-01-21       Impact factor: 5.742

6.  Modifier-concept of colorectal carcinogenesis: lipidomics as a technical tool in pathway analysis.

Authors:  Nikolaus Gassler; Christina Klaus; Elke Kaemmerer; Andrea Reinartz
Journal:  World J Gastroenterol       Date:  2010-04-21       Impact factor: 5.742

7.  Polymorphism within the distal RAD51 gene promoter is associated with colorectal cancer in a Polish population.

Authors:  Bartosz Mucha; Jacek Kabzinski; Adam Dziki; Karolina Przybylowska-Sygut; Andrzej Sygut; Ireneusz Majsterek; Lukasz Dziki
Journal:  Int J Clin Exp Pathol       Date:  2015-09-01

Review 8.  Genetic unraveling of colorectal cancer.

Authors:  Sabha Rasool; Vamiq Rasool; Tahira Naqvi; Bashir A Ganai; Bhahwal Ali Shah
Journal:  Tumour Biol       Date:  2014-02-27

9.  Dissecting characteristics and dynamics of differentially expressed proteins during multistage carcinogenesis of human colorectal cancer.

Authors:  Fang Peng; Ying Huang; Mao-Yu Li; Guo-Qing Li; Hui-Chao Huang; Rui Guan; Zhu-Chu Chen; Song-Ping Liang; Yong-Heng Chen
Journal:  World J Gastroenterol       Date:  2016-05-14       Impact factor: 5.742

10.  Presence of activating KRAS mutations correlates significantly with expression of tumour suppressor genes DCN and TPM1 in colorectal cancer.

Authors:  Vid Mlakar; Gasper Berginc; Metka Volavsek; Zdravko Stor; Miran Rems; Damjan Glavac
Journal:  BMC Cancer       Date:  2009-08-13       Impact factor: 4.430

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.